Fate Therapeutics, Inc.

Go to Fate Therapeutics, Inc. Website

$4.24

(%)
Live
Previous Close

$4.24

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$482.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is compri...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stifel cut the price target for Spire Global, Inc. (NYSE:SPIR) from $24 to $20. Stifel analyst Erik Rasmussen maintained a Buy rating. Spire Global shares fell 6.8% to close at $11.34 on Wednesday. See how other analysts view this stock. Oppenheimer boosted the price target for Analog Devices, Inc. (NASDAQ:ADI) from $215 to $245. Oppenheimer analyst Rick Schafer maintained an Outperform rating. Analog Devices shares rose 1.8% to close at $215.75 on Wednesday. See how other analysts view this stock. Goldman Sachs cut Sagimet Biosciences Inc.. (NASDAQ:SGMT) price target from $27 to $23. Goldman Sachs analyst Andrea Tan maintained a Buy rating. Sagimet Biosciences shares rose 5.5% to close ...Full story available on Benzinga.com

Related tickers: SPIR, ZBRA, ACN, ADI, OXY, POR, BABA, FATE, MNDY, SGMT.

Read Full Article

Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: FATE, ALLO.

Read Full Article
Trending Tickers
ITOS

XNAS

$17.96
(%)
MIMO

XASE

$0.11
(%)
PRSO

XNAS

$1.39
(%)
QQQ

XNAS

$0.00
(%)
$0.00
(%)